1.380CADMkt Cap: 404.92M CADP/E: —Last update: 2026-05-21
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activi…
Industry Peers
Diagnostics & Researchloading…
Indicators:|
Key Statistics
Company
Market Cap404.92M CAD
Enterprise Value425.71M CAD
Revenue (TTM)2.76M CAD
Gross Profit1.33M CAD
Net Income (TTM)-47.69M CAD
Revenue/Share0.0100 CAD
Last Price1.380 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees29
CountryCA
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)Infinity
PEG—
EV/EBITDA-39.93
EV/Revenue154.19
P/S146.66
P/B-5.80
EPS (TTM)-0.13
EPS (Forward)0.00
52W Range
1.37020% of range1.420
52W High1.420 CAD
52W Low1.370 CAD
Profitability
Gross Margin54.30%
Oper. Margin-362.51%
EBITDA Margin0.00%
Profit Margin-1952.99%
ROE68.40%
ROA-781.84%
Growth
Revenue Growth55.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.52M CAD
CapEx (TTM)195.00K CAD
FCF Margin625.33%
FCF Yield4.26%
Net Debt21.05M CAD
Net Debt/EBITDA-1.97
Balance Sheet
Debt/Equity-0.31
Current Ratio0.06
Quick Ratio0.04
Book Value/Sh-0.2380 CAD
Cash/Share0.0070 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateDec 19, 2011
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)3.150 CAD
Target Range2.800 CAD – 3.500 CAD
# Analysts2
Ownership
Shares Out.293.42M
Float288.39M
Insiders17.08%
Institutions12.44%
Short Interest
Short Ratio7.9d
Short % Out.0.11%
Shares Short313.21K
Short (prev mo.)323.38K
Technical
SMA 501.376 (+0.3%)
SMA 2001.373 (+0.5%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)158.86K
Avg Vol (10d)77.05K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—